Beam Therapeutics
Precision Medicine · Cell & Gene Therapy

Beam Therapeutics news and milestones

Beam Therapeutics: 9 headlines on record, 4 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 17, 2026 · Back to the company report
9Headlines
4In 90 days
2Milestones

Headlines

Sep 242026
News · YahooFinance
Beam Therapeutics sits in a crowded gene editing field, and its share price history raises a simple question for you as an investor: Is the current US$24.37 price properly reflec…
Sep 82026
News · markets.businessinsider.com
BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Unde...
Aug 312026
News · markets.businessinsider.com
CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic ...
Apr 112026
News · The Motley Fool
This precision genetic medicine developer reported a notable insider sale as it advances therapies for rare and serious diseases.
May 5, 20252025
News · Nasdaq
Precision gene-editing company Beam Therapeutics (NASDAQ: BEAM) had a Tuesday to forget on the stock market. Following the release that morning of its latest set of quarterly res…
Apr 24, 20252025
News · Nasdaq
In the absence of any marketed drugs, investors are set to focus on BEAM's pipeline updates when it reports first-quarter 2025 earnings.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Beam Therapeutics, News. Alion, Nov 17, 2026. https://alion.io/company/beamtx/news

.json · .md · CC BY-SA 4.0